1. Home
  2. CSTL vs DAKT Comparison

CSTL vs DAKT Comparison

Compare CSTL & DAKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSTL
  • DAKT
  • Stock Information
  • Founded
  • CSTL 2007
  • DAKT 1968
  • Country
  • CSTL United States
  • DAKT United States
  • Employees
  • CSTL N/A
  • DAKT N/A
  • Industry
  • CSTL Medical Specialities
  • DAKT Office Equipment/Supplies/Services
  • Sector
  • CSTL Health Care
  • DAKT Industrials
  • Exchange
  • CSTL Nasdaq
  • DAKT Nasdaq
  • Market Cap
  • CSTL 576.3M
  • DAKT 633.6M
  • IPO Year
  • CSTL 2019
  • DAKT 1994
  • Fundamental
  • Price
  • CSTL $19.78
  • DAKT $12.88
  • Analyst Decision
  • CSTL Strong Buy
  • DAKT Strong Buy
  • Analyst Count
  • CSTL 6
  • DAKT 1
  • Target Price
  • CSTL $40.00
  • DAKT $26.00
  • AVG Volume (30 Days)
  • CSTL 403.1K
  • DAKT 627.4K
  • Earning Date
  • CSTL 05-01-2025
  • DAKT 03-05-2025
  • Dividend Yield
  • CSTL N/A
  • DAKT N/A
  • EPS Growth
  • CSTL N/A
  • DAKT N/A
  • EPS
  • CSTL 0.62
  • DAKT 0.04
  • Revenue
  • CSTL $332,069,000.00
  • DAKT $799,806,000.00
  • Revenue This Year
  • CSTL N/A
  • DAKT $0.81
  • Revenue Next Year
  • CSTL $6.01
  • DAKT $4.73
  • P/E Ratio
  • CSTL $32.29
  • DAKT $332.34
  • Revenue Growth
  • CSTL 51.09
  • DAKT N/A
  • 52 Week Low
  • CSTL $16.97
  • DAKT $8.81
  • 52 Week High
  • CSTL $35.84
  • DAKT $19.89
  • Technical
  • Relative Strength Index (RSI)
  • CSTL 36.62
  • DAKT 45.21
  • Support Level
  • CSTL $19.22
  • DAKT $11.76
  • Resistance Level
  • CSTL $20.30
  • DAKT $13.09
  • Average True Range (ATR)
  • CSTL 0.81
  • DAKT 0.46
  • MACD
  • CSTL 0.23
  • DAKT 0.13
  • Stochastic Oscillator
  • CSTL 43.33
  • DAKT 84.21

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME, among others. The company's test portfolio consists of test offerings to aid clinicians in the diagnosis and treatment of cancers or precancerous diagnoses in the fields of dermatology, gastroenterology, and ophthalmology and a pharmacogenomics ("PGx") test to guide optimal drug treatment for patients diagnosed with depression, anxiety, and other mental health conditions.

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

Share on Social Networks: